Erlonat 100mg Tablet
Brand Name | Erlonat 100mg Tablet |
Salt Composition |
Erlotinib (100mg) |
Strength | 100mg |
Product Form | Tablet |
Pack | 30 Tablet(s) in strip |
Storage | Store below 30°C |
Category |
Anti-Cancer |
SubCategory |
Lung Cancer |
Country of Origin | India |
Manufacturer |
Natco Pharma Ltd |
Manufacturer/Marketer Address | Natco Pharma Ltd,Natco House, Road No:2, Banjara Hills, Hyderabad, (A.P ) 500 033 India |
You Save : Rs.1,998.00 Inclusive of all taxes
- Do not take this medicine if you are allergic to Erlotinib
- It is contraindicated to use this medicine in patients who are having interstitial lung disorder and lactose intolerance
- Rash
- Anorexia
- Diarrhea
- Fatigue
- Infection
- Dyspnea
- Stomatitis
- Conjunctivitis
- Dry skin
- Pruritus
- Abdominal pain
- Weight loss
- Pulmonary fibrosis
- Pneumonitis pulmonary infiltrate
- When should I call my doctor during treatment with an Erlonat 100mg Tablet?
- When can I plan a pregnancy if I am taking an Erlonat 100mg Tablet?
- Does smoking interfere with Erlonat 100mg Tablet?
- The use of this medicine may increase the risk for developing fatal interstitial lung disease, GI perforation, severe bullous, blistering, and exfoliating skin conditions
- Smoking reduces the plasma concentration of the erlotinib
- Kindly monitor the patient's renal function and electrolytes who are having a history of dehydration and severe renal toxicity
- Therapy should be administered with caution because the use of this medicine may increase the risk of developing myocardial infarction, ischemia
- The use of this medicine may increase the risk of developing cerebrovascular accidents and microangiopathic hemolytic anemia in patients with pancreatic cancer
- Ocular disorders include decreased tear production, abnormal eyelash growth, corneal perforation, ulceration, keratoconjunctivitis, and keratitis.
- The use of this medicine may cause diarrhea
- You are not responding to the treatment
- You have experienced any allergic reaction like rashes and itching
- You have a receiving any concomitant medication and disease
- Stored at 10-30°C room temperature.
- Protect from light and heat.
- Keep away from children and pets. Otherwise, it becomes toxic to them.
- Disposed of properly in a suitable bag.
- Erlonat 100mg Tablet contains Erlotinib 100mg used to treat non-small cell lung cancer and pancreatic cancer by inhibiting the activity of an abnormal protein that signals the cancer cells to multiply and this helps to stop the growth of cancer cells. This medication is recommended only for adults.
- Take this medicine 1 hour before or 2 hours after your meal
- The use of this medicine can make your skin sensitive so apply sunscreen and wear protective clothing
- Avoid smoking while you are receiving this medicine
- Kindly inform your doctor if you have noticed ulceration in your mouth.
Medical Description of Erlonat 100mg Tablet
Erlonat 100mg Tablet contains Erlotinib 100mg used to treat non-small cell lung cancer and pancreatic cancer by inhibiting the activity of an abnormal protein that signals the cancer cells to multiply and this helps to stop the growth of cancer cells. This medication is recommended only for adults.
Erlonat 100mg Tablet Uses
It is used in the treatment of the following conditions as non-small cell lung cancer and pancreatic cancer.
Erlonat 100mg Tablet Benefits
Non-small cancer lung cancer
It is a type of lung cancer. It grows and spreads slowly when compared with small cell lung cancer. Smoking is considered a major risk factor for non-small cancer lung cancer. Symptoms include chronic cough, shortness of breath, chest pain, bone pain, and headache.
Pancreatic cancer
It is a type of cancer that develops when an uncontrolled growth of cells begins in a part of the pancreas. It is usually caused by smoking and diabetes. Symptoms include abdominal pain, loss of appetite, itchy skin, fatigue, blood clots, dark-colored urine.
Erlonat 100mg Tablet Indication
The Erlonat 100mg Tablet is prescribed in the following indications as non-small cell lung cancer and pancreatic cancer.
Mechanism of action of Erlonat 100mg Tablet
Erlonat 100mg Tablet contains Erlotinib 100mg is an anti-cancer medication, tyrosine kinase inhibitor and epidermal growth factor receptor inhibitor inhibits phosphotyrosine present in epithelial growth factor receptors thus the signaling process for angiogenesis and proliferation of abnormal cells is inhibited. Thus, the abnormal cells minimize the growth of abnormal cancer cells and terminate metastasis of tumors or cancers
How Erlonat 100mg Tablet works
Erlonat 100mg Tablet contains Erlotinib 100mg is an anti-cancer medication, tyrosine kinase inhibitor and epidermal growth factor receptor inhibitor inhibits phosphotyrosine present in epithelial growth factor receptors thus the signaling process for angiogenesis and proliferation of abnormal cells is inhibited. Thus, the abnormal cells minimize the growth of abnormal cancer cells and terminate metastasis of tumors or cancers
Erlonat 100mg Tablet Contraindication
Erlonat 100mg Tablet Side Effects
FAQs for Erlonat 100mg Tablet
Kindly inform your doctor if you have experienced sudden difficulty in breathing, cough, fever, diarrhea, loss of appetite, nausea, and vomiting. Also, inform your doctor if you have to take any medication to control cholesterol.
Avoid planning for pregnancy while you are receiving this medicine and also use an effective contraceptive for at least 1 month after taking the last medicine.
Yes, smoking reduces the effectiveness of the medicine. Kindly avoid smoking while you are receiving this treatment.
Precautions and general warning of Erlonat 100mg Tablet
Alcohol
It is not clear that consuming alcohol is safe while you are receiving this medicine. Kindly consult with your doctor.
Driving or operating machinery
It is not known whether it is safe to drive or operate heavy machinery while receiving this medication. Kindly consult with your doctor.
Pregnancy
The use of this medicine is considered unsafe during pregnancy because it may produce any harmful effects. Kindly consult with your doctor
Breast Feeding
The use of this medicine is considered unsafe during breastfeeding because it may produce any harmful effects. Kindly consult with your doctor
Kidney Problem
It is considered safe to use this medicine in patients who are having a renal impairment. Kindly consult with your doctor.
Liver Disease
The medicine should be used with caution in patients with hepatic impairment. The use of this medicine required dose modification. Kindly consult with your doctor.
How to Take Erlonat 100mg Tablet
Erlonat 100mg Tablet is taken orally with or without food. You should not chew, cut or crush the tablet. Initially start with a low dose and slowly increase the dose once every week. Follow the direction mentioned within the label if you probably did not understand the appliance kindly ask your doctor or pharmacist to elucidate in detail. Do not withdraw the medicine when you feel better kindly complete the course of treatment to avoid reoccurrence.
Use of Erlonat 100mg Tablet in Adult
It is considered to be safe to use this medicine in an adult patient if the drug is prescribed by a doctor. Kindly consult with your doctor
Use of Erlonat 100mg Tablet in children
Safety and efficacy were not established in children who are below 18 years old. Kindly consult with your doctor.
Use of Erlonat 100mg Tablet in Elderly Patients
Erlonat 100mg Tablet should be used with caution in patients with an elderly age group, which leads to developing further medical problems, leads to worsening the patient's health conditions. Kindly consult with your doctor. Dose modification or replacement is required based on the medical conditions of the patient.
Other general warnings
Talk to your doctor if
General instructions
Erlotinib 100mg is used to treat non-small cell lung cancer and pancreatic cancer. Erlotinib 100mg is an anti-cancer medication, tyrosine kinase inhibitor, and epidermal growth factor receptor inhibitor that inhibits phosphotyrosine present in epithelial growth factor receptors thus the signaling process for angiogenesis and proliferation of abnormal cells is inhibited. Thus, the abnormal cells minimize the growth of abnormal cancer cells and terminate metastasis of tumors or cancers
Drug Interaction of Erlonat 100mg Tablet
Drug-Drug Interaction
Dexlansoprazole + Erlotinib
The use of this drug is contraindicated because the use of dexlansoprazole decreases the effect of erlotinib by others.
Chloramphenicol + Erlotinib
Therapy should be administered with caution because the use of chloramphenicol will increase the effect of erlotinib by affecting patient hepatic and intestinal enzyme metabolism
Ketoconazole + Erlotinib
Therapy should be administered with caution because the use of ketoconazole will increase the effect of erlotinib by affecting patient hepatic and intestinal enzyme metabolism
Tipranavir + Erlotinib
Therapy should be administered with caution because the use of tipranavir will increase the effect of erlotinib by affecting patient hepatic and intestinal enzyme metabolism
Carbamazepine + Erlotinib
Use alternative drugs because the use of carbamazepine will decrease the effect of erlotinib by affecting patient hepatic and intestinal enzyme metabolism.
Drug-Food Interaction
Erlotinib should be taken on an empty stomach one hour before the meal or 2 hours after the meal. You should also avoid grapefruit juice while you are receiving this medicine it may increase the erlotinib in blood levels.
Drug-Disease Interaction
GI disorders
Therapy should be administered with caution in patients with gastrointestinal disorders because the use of epidermal growth factor inhibitors is associated with gastrointestinal perforation.
Ocular disorders
Therapy should be administered with caution in patients with ocular disorders such as primary keratitis, ulcerative keratitis, and conjunctivitis.
Pulmonary toxicity
Therapy should be administered with caution in patients with a history of interstitial pneumonia because the use of certain epidermal growth factor inhibitors may cause pulmonary toxicity.
Hepatic and renal impairment
The use of epidermal growth factor inhibitor should be administered with caution in patients with renal and hepatic impairment. During the therapy monitor the patient hepatic functions like transaminases, bilirubin, and alkaline phosphatase.
Over Dose
Take the medicine as directed by the doctor don’t overdose on the medicine. If you have taken an overdose of this medicine immediately meet the doctor and rush to the nearby hospital.
Missed Dose
Take the medicine as directed by the doctor. Do not skip the medicine, if you forgot to take the medicine or missed the dose. It is almost time for your next dose, skip the missed dose and go back to your regular schedule. Don’t take the extra dose take the regular dose immediately. Don’t use the two-dose at one time (Double Dose).
Storage and Disposal
Fast Tag